Document is current
Any future updates will be listed below
-
Authors
Salvador-MartÃnez, Irepan https://orcid.org/0000-0002-3188-9784
Murga-Moreno, Jesus https://orcid.org/0000-0002-1812-0399
Nieto, Juan C. https://orcid.org/0000-0002-3400-1488
Alsinet, Clara https://orcid.org/0000-0002-7779-0667
Enard, David https://orcid.org/0000-0003-2634-8016
Heyn, Holger https://orcid.org/0000-0002-3276-1889
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (NIGMS 5R35GM142677)
- License Information
-
More Information
Article History
Received: 28 September 2023
Accepted: 14 November 2024
First Online: 28 November 2024
Competing interests
: H.H. is a co-founder and shareholder of Omniscope, a member of the Scientific Advisory Board of Nanostring and MiRXES, and a consultant to Moderna and Singularity. J.C.N. is a consultant to Omniscope. The remaining authors declare no competing interests.
